RE:RE:RE:RE:RE:RE:RE:Yet another tweet about SGLT2 inhibitorsThe latest Presentation Deck section that details their Milestones for next 2 months has now slipped in the word "anticipates" into the verbage so sounds like Howie is already trying to give himself an out should they not meet these timelines. And when have they ever....ever....ever met a deadline? I have a hard time recalling one instance where they nailed a deadline and over delivered on anything? If they can't deliver there should be calls for Howard to go do his doctor thing and hire a competent CEO cause his learn as you go method ain't an optimal way to guide a company to success.
The one thing that is going to get SBM's share price out of the penny status is contracts with substantial revenue. Whether it is upfront or ongoing they need revenue. Or a compound so valuable it makes them an obvious take over target and creates a premium on their share price.